.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Moodys
Healthtrust
Fuji
Merck
Farmers Insurance
Harvard Business School
US Army
Mallinckrodt
McKesson

Generated: July 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 200904

« Back to Dashboard
NDA 200904 describes LINEZOLID, which is a drug marketed by Hq Spclt Pharma, Sandoz Inc, Gate Pharms, Aurobindo Pharma Ltd, Alkem Labs Ltd, Teva Pharms, Novel Labs Inc, Alembic Pharms Ltd, Amneal Pharms, Hetero Labs Ltd V, Hospira Inc, Mylan Pharms Inc, Nang Kuang Pharm Co, Teva Pharms Usa, Fresenius Kabi Usa, West-ward Pharms Int, Glenmark Pharms, Sagent Pharms, and Zydus Pharms Usa Inc, and is included in twenty NDAs. It is available from twenty suppliers. Additional details are available on the LINEZOLID profile page.

The generic ingredient in LINEZOLID is linezolid. There are twenty-two drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the linezolid profile page.

Summary for NDA: 200904

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 200904

Ingredient-typeOxazolidinones

Suppliers and Packaging for NDA: 200904

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LINEZOLID
linezolid
SOLUTION;IV (INFUSION) 200904 ANDA Sandoz Inc 0781-3431 0781-3431-46 100 mL in 1 BAG (0781-3431-46)
LINEZOLID
linezolid
SOLUTION;IV (INFUSION) 200904 ANDA Sandoz Inc 0781-3431 0781-3431-95 10 BAG in 1 CARTON (0781-3431-95) > 100 mL in 1 BAG

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;IV (INFUSION)Strength200MG/100ML (2MG/ML)
Approval Date:Jul 16, 2015TE:APRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;IV (INFUSION)Strength600MG/300ML (2MG/ML)
Approval Date:Jul 16, 2015TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Express Scripts
UBS
Harvard Business School
Dow
AstraZeneca
Colorcon
Healthtrust
Moodys
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot